Form 4: Exelon Director Charisse R. Lillie Reports Acquisition of Deferred Stock Units

Charisse R. Lillie, an Exelon director, reported the acquisition of 1,131 deferred stock units and holdings of common stock and phantom share equivalents as of March 31, 2024.

Summary

• On March 31, 2024, Charisse R. Lillie, a director of Exelon Corp, acquired 1,131 shares of common stock in the form of deferred stock units at a price of $36.48 per unit.
• Following this transaction, Lillie directly owns 7,246 shares of Exelon common stock.
• Lillie also indirectly owns 4,010 shares of common stock through the Exelon Corp. Directors Deferred Stock Unit Plan.
• Additionally, Lillie holds 3,587 deferred phantom share equivalents in an Exelon stock fund account, which will be settled for cash upon termination of her service to the board.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, reporting routine transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The deferred phantom share equivalents will be settled for cash upon the termination of the reporting person's service to the board of directors.

Industry Context

This Form 4 filing is a routine disclosure of a company insider's transactions in the company's securities, as required by the SEC. It provides transparency to the market regarding the actions of company directors.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• The acquisition of deferred stock units aligns the director's interests with those of the shareholders.

Key Dates